Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
2104079 | Biology of Blood and Marrow Transplantation | 2010 | 6 Pages |
Abstract
Chronic graft-versus-host disease (cGVHD), a multiorgan disorder, is the leading cause of late nonrelapse mortality (NRM) after hematopoietic stem cell transplantation (HSCT). Despite many years of experience with this disease we are still faced with numerous challenges including (among others); lack of reliable preclinical models, poor knowledge of human pathophysiology, validated diagnostic and severity criteria, and unpredictable clinical response to first line treatment. We will review recent advances on the 3 last mentioned unresolved areas.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Gerard Socie, Jerome Ritz, Paul J. Martin,